Verition Fund Management
BNGO icon

Verition Fund Management’s Bionano Genomics BNGO Stock Holding History

Verition Fund Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-167
Closed -$18.9K – 2777
2023
Q4 		$18.9K Sell
167
-83
-33% -$8.67K ﹤0.01% 2213
2023
Q3 		$45.5K Buy
250
+100
+67% +$26.2K ﹤0.01% 2192
2023
Q2 		$54.9K Buy
150
+9
+6% +$4.06K ﹤0.01% 2031
2023
Q1 		$94.1K Buy
141
+90
+176% +$79.9K ﹤0.01% 1915
2022
Q4 		$44.4K Buy
+51
New +$64.2K ﹤0.01% 1893

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Verition Fund Management's BNGO Position: Q1 2024 in Review

Verition Fund Management sold out of Bionano Genomics (BNGO) in Q1 2024, closing a stake of 167 shares — an estimated $18.9K sold.

Verition Fund Management first reported a position in BNGO in Q4 2022 and held it in 5 quarters. The position peaked at $94.1K in Q1 2023. 55 funds tracked by Wall St. Rank hold BNGO as of Q1 2024.

  • Verition Fund Management reported no remaining Bionano Genomics position as of Q1 2024 after selling out during the quarter.
  • Verition Fund Management sold 167 Bionano Genomics shares in Q1 2024, an estimated $18.9K.
  • Verition Fund Management first reported a position in Bionano Genomics in Q4 2022 and held it in 5 quarters.
  • Verition Fund Management's Bionano Genomics position peaked at $94.1K in Q1 2023.
  • 55 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2024.

Based on Verition Fund Management's 13F filing for Q1 2024, filed 14 May 2024.